These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25402324)

  • 41. MEK inhibitor trametinib in combination with gemcitabine regresses a patient-derived orthotopic xenograft (PDOX) pancreatic cancer nude mouse model.
    Kawaguchi K; Igarashi K; Miyake K; Lwin TM; Miyake M; Kiyuna T; Hwang HK; Murakami T; Delong JC; Singh SR; Clary B; Bouvet M; Unno M; Hoffman RM
    Tissue Cell; 2018 Jun; 52():124-128. PubMed ID: 29857821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High Efficacy of Pazopanib on an Undifferentiated Spindle-Cell Sarcoma Resistant to First-Line Therapy Is Identified With a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
    Igarashi K; Kawaguchi K; Murakami T; Kiyuna T; Miyake K; Singh AS; Nelson SD; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM
    J Cell Biochem; 2017 Sep; 118(9):2739-2743. PubMed ID: 28176365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice.
    Zhao M; Yang M; Ma H; Li X; Tan X; Li S; Yang Z; Hoffman RM
    Cancer Res; 2006 Aug; 66(15):7647-52. PubMed ID: 16885365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts.
    Miyazaki S; Kikuchi H; Iino I; Uehara T; Setoguchi T; Fujita T; Hiramatsu Y; Ohta M; Kamiya K; Kitagawa K; Kitagawa M; Baba S; Konno H
    Int J Cancer; 2014 Jul; 135(2):295-307. PubMed ID: 24375080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exquisite Tumor Targeting by Salmonella A1-R in Combination with Caffeine and Valproic Acid Regresses an Adult Pleomorphic Rhabdomyosarcoma Patient-Derived Orthotopic Xenograft Mouse Model.
    Igarashi K; Kawaguchi K; Zhao M; Kiyuna T; Miyake K; Miyake M; Nelson SD; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Higuchi T; Singh SR; Tsuchiya H; Hoffman RM
    Transl Oncol; 2020 Feb; 13(2):393-400. PubMed ID: 31896528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Salmonella typhimurium A1-R and Cell-Cycle Decoy Therapy of Cancer.
    Hoffman RM; Yano S
    Methods Mol Biol; 2016; 1409():165-75. PubMed ID: 26846810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imaging the Different Mechanisms of Prostate Cancer Cell-killing by Tumor-targeting Salmonella typhimurium A1-R.
    Uchugonova A; Zhang Y; Salz R; Liu F; Suetsugu A; Zhang L; Koenig K; Hoffman RM; Zhao M
    Anticancer Res; 2015 Oct; 35(10):5225-9. PubMed ID: 26408681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drug.
    Murakami T; Igarashi K; Kawaguchi K; Kiyuna T; Zhang Y; Zhao M; Hiroshima Y; Nelson SD; Dry SM; Li Y; Yanagawa J; Russell T; Federman N; Singh A; Elliott I; Matsuyama R; Chishima T; Tanaka K; Endo I; Eilber FC; Hoffman RM
    Oncotarget; 2017 Jan; 8(5):8035-8042. PubMed ID: 28030831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor-Targeting Salmonella typhimurium A1-R in Combination with Trastuzumab Eradicates HER-2-Positive Cervical Cancer Cells in Patient-Derived Mouse Models.
    Hiroshima Y; Zhang Y; Zhao M; Zhang N; Murakami T; Maawy A; Mii S; Uehara F; Yamamoto M; Miwa S; Yano S; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Endo I; Hoffman RM
    PLoS One; 2015; 10(6):e0120358. PubMed ID: 26047477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor-Targeting Salmonella typhimurium A1-R Arrests a Chemo-Resistant Patient Soft-Tissue Sarcoma in Nude Mice.
    Hiroshima Y; Zhao M; Zhang Y; Zhang N; Maawy A; Murakami T; Mii S; Uehara F; Yamamoto M; Miwa S; Yano S; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Endo I; Hoffman RM
    PLoS One; 2015; 10(8):e0134324. PubMed ID: 26237416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methioninase Cell-Cycle Trap Cancer Chemotherapy.
    Hoffman RM; Yano S; Igarashi K
    Methods Mol Biol; 2019; 1866():133-148. PubMed ID: 30725413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of spontaneous and experimental lung metastasis of soft-tissue sarcoma by tumor-targeting Salmonella typhimurium A1-R.
    Miwa S; Zhang Y; Baek KE; Uehara F; Yano S; Yamamoto M; Hiroshima Y; Matsumoto Y; Kimura H; Hayashi K; Yamamoto N; Bouvet M; Tsuchiya H; Hoffman RM; Zhao M
    Oncotarget; 2014 Dec; 5(24):12849-61. PubMed ID: 25528763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.
    Bockhorn M; Tsuzuki Y; Xu L; Frilling A; Broelsch CE; Fukumura D
    Clin Cancer Res; 2003 Sep; 9(11):4221-6. PubMed ID: 14519649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated VEGF signaling pathway.
    Chen H; Zhang J; Luo J; Lai F; Wang Z; Tong H; Lu D; Bu H; Zhang R; Lin S
    Oncol Rep; 2013 Aug; 30(2):589-95. PubMed ID: 23754270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines.
    Fukasawa M; Korc M
    Clin Cancer Res; 2004 May; 10(10):3327-32. PubMed ID: 15161686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
    Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
    Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy.
    Yano S; Zhang Y; Zhao M; Hiroshima Y; Miwa S; Uehara F; Kishimoto H; Tazawa H; Bouvet M; Fujiwara T; Hoffman RM
    Cell Cycle; 2014; 13(24):3958-63. PubMed ID: 25483077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adjuvant treatment with tumor-targeting Salmonella typhimurium A1-R reduces recurrence and increases survival after liver metastasis resection in an orthotopic nude mouse model.
    Murakami T; Hiroshima Y; Zhao M; Zhang Y; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    Oncotarget; 2015 Dec; 6(39):41856-62. PubMed ID: 26497690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.